ELMD
AMEXElectromed Inc.
Electromed Inc. (ELMD) is a Biotechnology: Electromedical & Electrotherapeutic Apparatus company listed on AMEX. In the last 30 days Quantisnow tracked 4 wire items for ELMD, including 2 earnings updates and 2 SEC filings. The most recent was published Nov 10, 2026.
Financial highlights
Full financials- Revenue, TTM
- $75.57M
- Revenue growth
- +14.1%
- Net income, TTM
- $11.93M
- Net margin
- 15.8%
- Free cash flow, TTM
- $8.70M
- Cash
- $15.88M
For the twelve months ended Sep 30, 2026, from SEC filings. Not investment advice.
News · 26 weeks19+100%
2026-05-172026-11-08
Mix1390d
- SEC Filings6(46%)
- Earnings3(23%)
- Insider2(15%)
- Leadership1(8%)
- Other1(8%)
Activity · 52 weeks3720 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news
Latest news
25 items- SECSEC Form 10-Q filed by Electromed Inc.10-Q - Electromed, Inc. (0001488917) (Filer)
- SECElectromed Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Electromed, Inc. (0001488917) (Filer)
- PRElectromed, Inc. Delivers Continued Growth in Fiscal 2027 First Quarter16th consecutive quarter of year-over-year revenue and operating income growth Electromed, Inc. ("Electromed") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended September 30, 2026 ("Q1 FY 2027"). Q1 FY 2027 Company Highlights Net revenues were $18.7 million in Q1 FY 2027, a 10.6% increase from $16.9 million in the first quarter of the prior fiscal year, driven by a 17.6% increase in the core homecare market. Operating income increased to $3.5 million, a 30.7% increase from the first quarter of the prior fiscal year, and 18.7% of net revenues. Net income was $2.8 million, or $0.32 per diluted share, re
- PRElectromed, Inc. to Report Q1 Fiscal 2027 Financial Results on November 10, 2026Electromed, Inc. ("Electromed") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2027 first quarter ended September 30, 2026, on Tuesday, November 10, 2026, after the close of the stock market. Company management will host a conference call on the same day at 5:00 p.m. Eastern Time to discuss the results. Interested parties may participate in the call by dialing (877) 407-3982 (Toll Free) or (201) 493-6780. The live webcast of the call will be accessible in the Investor Relations section of Electromed’s website and directly via the following link: Electromed's Q1 Fiscal 2027 Earnings
- SECSEC Form DEF 14A filed by Electromed Inc.DEF 14A - Electromed, Inc. (0001488917) (Filer)
- SECSEC Form DEFA14A filed by Electromed Inc.DEFA14A - Electromed, Inc. (0001488917) (Filer)
- PRElectromed, Inc. to Participate in the H.C. Wainwright 28th Annual Global Investment Conference and LD Micro 20th Annual Main EventElectromed, Inc. ("Electromed") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced their attendance at the HC Wainwright 28th Annual Global Investment Conference being held September 14-16, 2026, in New York. Jim Cunniff, Electromed’s President and Chief Executive Officer, will present at 3:30 ET on Monday, September 14, 2026. Management will also host one-on-one meetings with investors. Electromed will also be attending the LD Micro 20th Annual Main Event being held October 19-21, 2026, in Los Angeles. Jim Cunniff will be presenting during the event, and the Company will be hosting one-on-one meetings with investors. Links to the live webcast of each pre
- INSIDERSEC Form 4 filed by Electromed Inc.4 - Electromed, Inc. (0001488917) (Issuer)
- INSIDERSEC Form 4 filed by Electromed Inc.4 - Electromed, Inc. (0001488917) (Issuer)
- SECElectromed Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Electromed, Inc. (0001488917) (Filer)
- SECSEC Form 10-K filed by Electromed Inc.10-K - Electromed, Inc. (0001488917) (Filer)
- PRElectromed Announces CEO’s Planned RetirementElectromed, Inc. (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced that Jim Cunniff expects to retire as President and Chief Executive Officer, on or about April 2, 2027. Upon his retirement, he will resign from the Company’s Board of Directors. The Board of Directors intends to conduct a national search for Electromed’s next President and Chief Executive Officer and has engaged an executive search firm to assist in the process. Mr. Cunniff has served as the Company’s President and Chief Executive Officer and as a member of its Board of Directors since 2023. During his tenure, he has strengthened Electromed’s position as a leader in HFCWO airway clearance
- PRElectromed, Inc. Announces Record Fiscal 2026 Fourth Quarter and Full Year Financial ResultsStrong homecare revenue growth and expanded operating leverage drive record operating income in Fiscal 2026 Electromed, Inc. ("Electromed") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ("Q4 FY 2026") and full year ended June 30, 2026 ("FY 2026"). Q4 FY 2026 Company Highlights Net revenue increased 11.6% to a record $19.4 million in Q4 FY 2026, from $17.4 million in the fourth quarter of the prior fiscal year. Operating income increased 25.8% over the prior year to a record $3.8 million, or 19.7% of net revenues. Net income increased 54.3% to a record $3.4 million, or $0.39 per diluted share, compared t
- PRElectromed, Inc. to Report Q4 Fiscal 2026 Financial Results on August 25, 2026Electromed, Inc. ("Electromed" or the "Company") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2026 fourth quarter ended June 30, 2026, on Tuesday, August 25th, 2026, after the close of the stock market. Company management will host a conference call on the same day at 5:00 p.m. Eastern Time to discuss the results. Interested parties may participate in the call by dialing (877) 407-3982 (Toll Free) or (201) 493-6780. The live webcast of the call will be accessible in the Investor Relations section of Electromed’s website and directly via the following link: Electromed Fiscal Q4 202
- INSIDERChief Financial Officer Nagel Bradley M. covered exercise/tax liability with 674 shares, decreasing direct ownership by 3% to 18,964 units (SEC Form 4) (for tax liability)4 - Electromed, Inc. (0001488917) (Issuer)
- INSIDERCEO and President Cunniff James L. exercised 9,700 shares at a strike of $17.25 and sold $354,095 worth of shares (9,700 units at $36.50) (SEC Form 4)4 - Electromed, Inc. (0001488917) (Issuer)
- INSIDERChief Financial Officer Nagel Bradley M. exercised 9,601 shares at a strike of $10.50 and sold $428,936 worth of shares (11,801 units at $36.35), decreasing direct ownership by 10% to 19,638 units (SEC Form 4)4 - Electromed, Inc. (0001488917) (Issuer)
- SECSEC Form SD filed by Electromed Inc.SD - Electromed, Inc. (0001488917) (Filer)
- INSIDERDirector Skarvan Kathleen exercised 40,000 shares at a strike of $3.82 and sold $1,419,358 worth of shares (40,000 units at $35.48) (SEC Form 4)4 - Electromed, Inc. (0001488917) (Issuer)
- SECSEC Form 10-Q filed by Electromed Inc.10-Q - Electromed, Inc. (0001488917) (Filer)
- SECElectromed Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Electromed, Inc. (0001488917) (Filer)
- PRElectromed, Inc. Announces Record Financial Performance in Fiscal 2026 Third Quarter18% Revenue growth and strong operating leverage exceeds consensus expectations for the third quarter of fiscal 2026 Electromed, Inc. ("Electromed") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three and nine months ended March 31, 2026 ("Q3 FY 2026"). Q3 FY 2026 Company Highlights Net revenues increased 18.4% to a record $18.6 million in Q3 FY 2026, from $15.7 million in the third quarter of the prior fiscal year, led by an 18.6% increase in the core homecare market. Operating income increased to a record $3.8 million, a 76.0% increase from the third quarter of the prior fiscal year, and 20.3% of net revenues. Net
- PRElectromed, Inc. to Report Q3 Fiscal 2026 Financial Results on May 12, 2026Electromed, Inc. ("Electromed" or the "Company") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2026 third quarter ended March 31, 2026, on Tuesday, May 12, 2026 after the close of the stock market. Company management will host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results. Interested parties may participate in the call by dialing (877) 407-3982 (Toll Free) or (201) 493-6780. The live webcast of the call will be accessible in the Investor Relations section of Electromed's website and directly via the following link: Electromed Fiscal Q3 2026 Earning
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Electromed Inc.SCHEDULE 13G/A - Electromed, Inc. (0001488917) (Subject)
- SECSEC Form 10-Q filed by Electromed Inc.10-Q - Electromed, Inc. (0001488917) (Filer)
ELMD FAQ
11 questionsWhat does Electromed Inc. do?
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management...What is the latest news on ELMD?
In the last 30 days Quantisnow tracked 4 wire items for ELMD: 2 earnings updates and 2 SEC filings. The most recent was published on November 10, 2026.What is ELMD revenue?
Electromed Inc. (ELMD) reported $75.57M of revenue for the twelve months ended Sep 30, 2026. That is up 14.1% from the year before. Revenue for fiscal 2026 was $73.78M.Is ELMD profitable?
Yes. Electromed Inc. earned $11.93M in net income for the twelve months ended Sep 30, 2026, a net margin of 15.8%.How much cash and debt does ELMD have?
Electromed Inc. reported $15.88M in cash and cash equivalents on its most recent balance sheet in SEC filings.Where does ELMD stock trade?
Electromed Inc. (ELMD) is listed on AMEX.What sector and industry is ELMD in?
Electromed Inc. operates in the Health Care sector, Biotechnology: Electromedical & Electrotherapeutic Apparatus industry.When did Electromed Inc. go public?
Electromed Inc. (ELMD) completed its IPO in 2011.What are analysts saying about ELMD?
Electromed Inc. has had 3 recent analyst actions on file. The most recent action was from Lake Street: Buy with a $36.00 price target on 2025-08-27. Recent price targets range from $29.00 to $38.00.What companies are similar to ELMD?
Notable peers in the same industry include INMD (InMode Ltd.), AXGN (Axogen Inc.), TMDX (TransMedics Group Inc.), MDT (Medtronic plc.), LIVN (LivaNova PLC). Compare ELMD side-by-side with any of them on Quantisnow.How can I track ELMD on Quantisnow?
Quantisnow aggregates Electromed Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ELMD to receive live email and push alerts on every new disclosure.